» Articles » PMID: 12946886

The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), Clinician Rating (QIDS-C), and Self-report (QIDS-SR): a Psychometric Evaluation in Patients with Chronic Major Depression

Overview
Journal Biol Psychiatry
Publisher Elsevier
Specialty Psychiatry
Date 2003 Aug 30
PMID 12946886
Citations 1503
Authors
Affiliations
Soon will be listed here.
Abstract

The 16-item Quick Inventory of Depressive Symptomatology (QIDS), a new measure of depressive symptom severity derived from the 30-item Inventory of Depressive Symptomatology (IDS), is available in both self-report (QIDS-SR(16)) and clinician-rated (QIDS-C(16)) formats. This report evaluates and compares the psychometric properties of the QIDS-SR(16) in relation to the IDS-SR(30) and the 24-item Hamilton Rating Scale for Depression (HAM-D(24)) in 596 adult outpatients treated for chronic nonpsychotic, major depressive disorder. Internal consistency was high for the QIDS-SR(16) (Cronbach's alpha =.86), the IDS-SR(30) (Cronbach's alpha =.92), and the HAM-D(24) (Cronbach's alpha =.88). QIDS-SR(16) total scores were highly correlated with IDS-SR(30) (.96) and HAM-D(24) (.86) total scores. Item-total correlations revealed that several similar items were highly correlated with both QIDS-SR(16) and IDS-SR(30) total scores. Roughly 1.3 times the QIDS-SR(16) total score is predictive of the HAM-D(17) (17-item version of the HAM-D) total score. The QIDS-SR(16) was as sensitive to symptom change as the IDS-SR(30) and HAM-D(24), indicating high concurrent validity for all three scales. The QIDS-SR(16) has highly acceptable psychometric properties, which supports the usefulness of this brief rating of depressive symptom severity in both clinical and research settings.

Citing Articles

Cognitive control circuit function predicts antidepressant outcomes: A signal detection approach to actionable clinical decisions.

Williams L, Yesavage J Pers Med Psychiatry. 2025; 45-46.

PMID: 40066316 PMC: 11890176. DOI: 10.1016/j.pmip.2024.100126.


Investigating the impact of electroconvulsive therapy on brain networks and sleep: an observational study protocol.

Kafashan M, Lebovitz L, Greenspan R, Zhao S, Kim T, Husain M BMJ Open. 2025; 15(3):e098859.

PMID: 40054874 PMC: 11891538. DOI: 10.1136/bmjopen-2025-098859.


A simple platelet biomarker is associated with symptom severity in major depressive disorder.

Gunay A, Targum S, Leow A, Ajilore O, Rasenick M Mol Psychiatry. 2025; .

PMID: 40038544 DOI: 10.1038/s41380-025-02941-1.


Exploring social impairment in those with opioid use disorder: linking impulsivity, childhood trauma, and the prefrontal cortex.

Costa Macedo de Arruda T, Sinko L, Regier P, Tufanoglu A, Curtin A, Teitelman A BMC Psychiatry. 2025; 25(1):197.

PMID: 40033258 PMC: 11877763. DOI: 10.1186/s12888-025-06503-1.


Neural signatures of emotional biases predict clinical outcomes in difficult-to-treat depression.

Fennema D, Barker G, ODaly O, Godlewska B, Carr E, Goldsmith K Res Dir Depress. 2025; 1:e21.

PMID: 40028885 PMC: 11869767. DOI: 10.1017/dep.2024.6.